Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Receivables - Other: 2010-2024

Historic Receivables - Other for Altimmune (ALT) over the last 9 years, with Dec 2024 value amounting to $400,000.

  • Altimmune's Receivables - Other rose 133.33% to $700,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $700,000, marking a year-over-year increase of 133.33%. This contributed to the annual value of $400,000 for FY2024, which is 300.00% up from last year.
  • Altimmune's Receivables - Other amounted to $400,000 in FY2024, which was up 300.00% from $100,000 recorded in FY2023.
  • Altimmune's Receivables - Other's 5-year high stood at $400,000 during FY2024, with a 5-year trough of $100,000 in FY2023.
  • Over the past 2 years, Altimmune's median Receivables - Other value was $250,000 (recorded in 2023), while the average stood at $250,000.
  • Data for Altimmune's Receivables - Other shows a peak YoY soared of 300.00% (in 2024) over the last 5 years.
  • Altimmune's Receivables - Other (Yearly) stood at $100,000 in 2023, then soared by 300.00% to $400,000 in 2024.